Clinical Trial Update: Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of rosuvastatin and atorvastatin in pediatric patients with dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Lipitor (atorvastatin)

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED